Form 8-K - Current report:
SEC Accession No. 0001213900-23-047870
Filing Date
2023-06-09
Accepted
2023-06-09 17:00:13
Documents
12
Period of Report
2023-06-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea180018-abvcbiopharma.htm   iXBRL 8-K 25076
  Complete submission text file 0001213900-23-047870.txt   196850

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20230609.xsd EX-101.SCH 2983
3 XBRL LABEL FILE abvc-20230609_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abvc-20230609_pre.xml EX-101.PRE 22375
6 EXTRACTED XBRL INSTANCE DOCUMENT ea180018-abvcbiopharma_htm.xml XML 3494
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231006147
SIC: 2834 Pharmaceutical Preparations